28.04.2016 17:00:01
|
DGAP-Stimmrechtsanteile: Probiodrug AG
DGAP-PVR: Correction of a release from 11.11.2014, 13:10 CET/CEST - Probiodrug AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Correction of publication of notification of voting rights pursuant to sec. 21 para. 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)
3.1
JPMorgan Asset Management (UK) Limited, London, United Kingdom, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion exceeded the threshold of 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on October 30, 2014, and that its voting rights proportion in Probiodrug AG amounted to 3.87% (corresponding to 260,000 voting rights). 3.87% (corresponding to 260,000 voting rights) are to be attributed to JPMorgan Asset Management (UK) Limited pursuant to sec. 22 para. 1 sentence 1 no. 6 WpHG.
Halle (Saale), in April 2016
The Management
28.04.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
--------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Probiodrug AG
28.04.2016 17:00
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Probiodrug AG
Halle (Saale), Germany
Handelsregister: Amtsgericht Stendal, HRB 213719
(Commercial Register: Local Court of Stendal, HRB 213719)
ISIN: DE0007921835
Publication pursuant to sec. 26 para 1 WpHG (Wertpapierhandelsgesetz -
German Securities Trading Act)
Correction of publication of notification of voting rights pursuant to sec. 21 para. 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)
3.1
JPMorgan Asset Management (UK) Limited, London, United Kingdom, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion exceeded the threshold of 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on October 30, 2014, and that its voting rights proportion in Probiodrug AG amounted to 3.87% (corresponding to 260,000 voting rights). 3.87% (corresponding to 260,000 voting rights) are to be attributed to JPMorgan Asset Management (UK) Limited pursuant to sec. 22 para. 1 sentence 1 no. 6 WpHG.
Halle (Saale), in April 2016
The Management
28.04.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
--------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Probiodrug AGmehr Nachrichten
Keine Nachrichten verfügbar. |